The upregulation of mRNA expression of several oncogenes, including FOSL2, TUFT1, HMGA1, and HDGF [38,39,40,41], most often leads to the acquisition of cisplatin resistance, while increasing the proliferation of cancer cells and reducing their apoptosis. This evidence concerns the gene FOSL2 and cancer.